Eltrombopag Improved Platelet Counts in Thrombocytopenic MDS Patients

The use of the thrombopoietin receptor agonist eltrombopag was clinically effective at raising platelet counts in patients with lower-risk myelodysplastic syndromes with severe thrombocytopenia.
Source: CancerNetwork - Category: Cancer & Oncology Authors: Tags: Hematologic Malignancies Myelodysplastic Syndromes News Source Type: news